The continuing saga of a wannabe GM who can't get a game started ...
I had planned to do two more "Comparative Character Generation" articles/reports/rants/things, but I'm not so sure.
I've lost interest in doing the games I mentioned last time. My infatuation with Warhammer Fantasy Roleplay 3rd edition is over, Mongoose RuneQuest II is mostly the same as Basic Roleplaying, and Unisystem as a whole doesn't do anything new.My original reason for these things, figuring out a system for my next game, proved faulty. My biggest problem is players,
Updated 09-16-2010 at 08:14 AM by fmitchell
After watching the Doctor's recent regeneration for the Nth time, I realized how to solve a persistent problem in Doctor Who RPGs: Time Lords rock, companions suck.
A traditional solution is to make all players Junior Time Lords. The Buffy game gives non-Slayers more Drama Points, and I'm sure some Doctor Who game has tried a similar equalizing factor. Another suggestion I've heard is that the Time Lord is an NPC Patron, who makes the Companions do all the work.
I've written another in the Comparative Character Generation series. I'm only going to do two more, since a) I've examined most of the systems I'm likely to find players for, as far as I know, and b) my real problem isn't the system I run.
So if anyone wants to see something besides PDQ, PDQ Sharp, FATE, Fudge, GURPS, BRP, MRQ, MRQ2, WFRP2, WFRP3, Unisystem, Barbarians of Lemuria, NWoD, Savage Worlds, Risus, or several variations on d20 ... speak now.
Updated 09-16-2010 at 08:16 AM by fmitchell
Three weeks ago, the players and I decided to suspend the Orc Lands campaign, due to the lack of new players and the number of times one absence cancelled the game.
I'm going to move the game to play-by-post at some point, although I'm not sure whether I should continue to run it as BRP.
Another installment in my continuing attempts to decide on another game to run. This time, I consider True20, Warhammer and Traveller, as well as various forms of D&D: E6, generic classes, and retro-clones.